Report Overview

2023

Base Year

2018-2023

Historical Year

2024-2032

Forecast Year

Polymyalgia Rheumatica Treatment Market Growth

Polymyalgia is usually treated with medications such as corticosteroids to ease symptoms and uneasiness. Steroids are one of the most common drugs for polymyalgia rheumatica treatment. It can ease pain and stiffness in a few days. However, the use of the drug requires extensive monitoring as it can lead to serious side effects, such as loss of bone density, cataracts, and high blood pressure. This leads to routine diagnostic tests to monitor the effect and treatment of the disease, hence augmenting the industry growth. Moreover, the growing demand for immune suppressing medications such as methotrexate in the early course of treatment is significantly contributing to the market growth.

 

In addition, the development of drugs that can treat various rheumatological diseases, such as polymyalgia rheumatica and rheumatoid arthritis, is propelling the market growth. This is expected to surge its demand among people with several health-related issues, to significantly contribute to the market growth. Moreover, the introduction of clinical programs by leading companies to evaluate the safety and efficiency of novel drugs is invigorating the growth of the polymyalgia rheumatica treatment industry.

 

Polymyalgia Rheumatica Treatment Market Report Snapshots

Polymyalgia Rheumatica Treatment Market Size

Polymyalgia Rheumatica Treatment Market Growth

Polymyalgia Rheumatica Treatment Companies

 

*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*

Looking for specific insights?

Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!

Key Questions Answered in the Report

In 2023, the market attained a value of nearly USD 203.73 million.

The market is projected to grow at a CAGR of 4.7% between 2024 and 2032.

The market is estimated to witness a healthy growth in the forecast period of 2024-2032 to reach around USD 308.68 million by 2032.

The increasing demand for 3D CAD software in major industry verticals, the surging demand for enhanced design and virtual testing technology, and the growing investments in R&D activities are the major drivers of the market.

The key trends propelling the market include rising digitalisation and rapid technological advancements.

The major regions in the market are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.

The major diagnostic methods of polymyalgia rheumatica treatment in the market are blood tests and imaging tests.

The significant drug classes considered in the market report are corticosteroids, disease-modifying anti-rheumatic drugs, and non-steroidal anti-inflammatory drugs, among others.

Oral and parenteral are the different routes of administration for polymyalgia rheumatica treatment.

The various end uses of polymyalgia rheumatica treatment are hospitals, homecare, and speciality clinics, among others.

The major players in the market are Sanofi SA, Apotex Corporation, GlaxoSmithKline plc, AbbVie Inc., and Horizon Therapeutics plc, among others.

Purchase Full Report

Datasheet

 

USD 2,969

USD 2,499

tax inclusive*

  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

One User

USD 5,499

USD 4,699

tax inclusive*

  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Five User License

Five Users

USD 6,599

USD 5,599

tax inclusive*

  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

Unlimited Users

USD 7,699

USD 6,599

tax inclusive*

  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

How To Order

Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.

Select License Type

Choose the right license for your needs and access rights.

Click on ‘Buy Now’

Add the report to your cart with one click and proceed to register.

Select Mode of Payment

Choose a payment option for a secure checkout. You will be redirected accordingly.

Strategic Solutions for Informed Decision-Making

Connect For More Information

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.

Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.

We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.

Back to top

We’re here to help answer any questions about our products and services.

Contact us

Our Offices


Australia

63 Fiona Drive, Tamworth, NSW

+61-448-061-727

India

C130 Sector 2 Noida, Uttar Pradesh 201301

+91-858-608-1494

Philippines

40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.

+63-287-899-028, +63-967-048-3306

United Kingdom

6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London

+44-753-713-2163

United States (Head Office)

30 North Gould Street, Sheridan, WY 82801

+1-415-325-5166

Vietnam

193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City

+84-865-399-124

30 North Gould Street, Sheridan, WY 82801

+1-415-325-5166

63 Fiona Drive, Tamworth, NSW

+61-448-061-727

C130 Sector 2 Noida, Uttar Pradesh 201301

+91-858-608-1494

40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City, 1226.

+63-287-899-028, +63-967-048-3306

6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London

+44-753-713-2163

193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City

+84-865-399-124

$getforecastarray = array(); if (isset($ismapshow)) { $forecast_period_start = isset($forecast_period_start) ? $forecast_period_start : ''; if ($forecast_period_start != "") { $yearInc = 1; for ($startfrom = $forecast_period_start; $startfrom <= $forecast_period_end; $startfrom++) { $calculatFercastYear=calculateFutureValue(($getReportDetail['base_value']> 0) ? $getReportDetail['base_value'] : 100, $getReportDetail['cagr'], $yearInc); $getforecastarray[] = array('years' => "$startfrom", 'value' => $calculatFercastYear); $yearInc++; } } } $getforecastarrayJson = json_encode($getforecastarray); ?>